Literature DB >> 8549387

Levofloxacin in patients with severe respiratory tract infection.

S Odagiri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549387     DOI： 10.2165/00003495-199500492-00123

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

Review 1.  Synergy and antagonism of combinations with quinolones.

Authors:  H C Neu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 2.  Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.

Authors:  J M Radandt; C R Marchbanks; M N Dudley
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

Review 3.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

4.  [Laboratory and clinical studies on levofloxacin].

Authors:  K Tanaka; M Iwamoto; S Maesaki; H Koga; S Kohno; K Hara; K Sugawara; M Kaku; S Kusano; O Sakito
Journal:  Jpn J Antibiot       Date:  1992-05
  4 in total
  1 in total

Review 1.  [Use of levofloxacine in primary care for outbreaks in COPD].

Authors:  R de Dios del Valle; A Hernández Sánchez; A Franco Vidal; J L Palancar de la Torre
Journal:  Aten Primaria       Date:  2001-04-15       Impact factor: 1.137
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.